UK Companies House feature
MC2 THERAPEUTICS LIMITED
Profile
- Company number
- 05349119
- Status
- Active
- Incorporation
- 2005-02-01
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21200
- Hubs
- UK Healthcare
Accounts
Pending extraction
No iXBRL extracted yet for this company.
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the directors' assessment they consider that there is sufficient working capital for the company to continue for a period of at least 12 months from the date of signing of the financial statements and therefore it is appropriate to prepare the financial statements on a going concern basis.”
Subsidiaries
- Disperse Pharma Limited · 100% held · England · Research and experimental development on biotechnology
- MC2 Therapeutics PTY LTD · 100% held · Sydney · Development and commercialization activities
Significant events
- “Subsequent to year-end 2024, MC2 Therapeutics has entered into agreements with partners in Australia and Canada to further strengthening the global roll-out of Wynzora® Cream.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
4 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HILTON, Tim | Secretary | 2024-12-19 | — | — |
| AHLGREEN, Trine | Director | 2026-01-27 | Aug 1975 | Danish |
| HARRISON, Christopher Neil | Director | 2025-12-18 | Nov 1971 | British |
| MIKKELSEN, Tomas Dahl | Director | 2022-12-22 | May 1980 | Danish |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| TWYDELL, Richard William | Secretary | 2005-02-01 | 2024-12-19 |
| BUDOLFSEN, Elsebeth | Director | 2005-11-04 | 2009-11-01 |
| CLAUSEN, Anette Merete Nohr | Director | 2005-07-12 | 2018-11-13 |
| CLAUSEN, Mads Jorgen Nohr | Director | 2008-06-25 | 2026-01-31 |
| CRUTCHLEY, Nigel, Dr | Director | 2018-11-13 | 2023-03-13 |
| LANGE, Jesper Jorn | Director | 2008-06-25 | 2022-12-22 |
| LENON, Stephen John, Dr | Director | 2005-02-01 | 2022-12-29 |
| PRAESTEGAARD, Morten | Director | 2018-11-13 | 2022-12-22 |
| PRIMROSE, Kenneth Mark | Director | 2005-11-04 | 2007-03-01 |
| SINDET PEDERSEN, Steen, Professor | Director | 2005-07-12 | 2012-12-31 |
| TWYDELL, Richard William | Director | 2005-02-01 | 2018-11-13 |
| WHEELER, Derek Alfred | Director | 2005-07-12 | 2018-11-13 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mc2 Therapeutics A/S | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 120 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-02-11 | CS01 | confirmation-statement | confirmation statement with updates |
| 2026-02-06 | TM01 | officers | termination director company with name termination date |
| 2026-01-27 | AP01 | officers | appoint person director company with name date |
| 2025-12-18 | AP01 | officers | appoint person director company with name date |
| 2025-10-24 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2025-10-06 | AA | accounts | accounts with accounts type full |
| 2025-02-04 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-01-07 | AP03 | officers | appoint person secretary company with name date |
| 2025-01-07 | TM02 | officers | termination secretary company with name termination date |
| 2024-09-28 | AA | accounts | accounts with accounts type small |
| 2024-02-13 | CS01 | confirmation-statement | confirmation statement with updates |
| 2023-12-21 | SH01 | capital | capital allotment shares |
| 2023-09-26 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-08-02 | AA | accounts | accounts with accounts type small |
| 2023-03-13 | TM01 | officers | termination director company with name termination date |
| 2023-02-03 | CS01 | confirmation-statement | confirmation statement with updates |
| 2022-12-29 | TM01 | officers | termination director company with name termination date |
| 2022-12-23 | SH01 | capital | capital allotment shares |
| 2022-12-22 | CH01 | officers | change person director company with change date |
| 2022-12-22 | TM01 | officers | termination director company with name termination date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires extracted accounts data.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.